Pricing Log in Create free account
Friday 6 November 2026 Export GRAL’s income statement to Excel — free account

GRAIL, Inc.

GRAL Healthcare Diagnostics & Research

GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.

Revenue
+3.71%
EPS
+10.2%
Free cash flow
−24.9%

Quarter to September 2026, against a year earlier

124.40 19.26 −13.41%
Market cap
$5.3B
P/E
0.0×
Fwd P/E
−14.5×
Dividend yield
—
F-score
6/9
Altman Z
0.37
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

GRAIL, Inc. (GRAL) EV/EBITDA

Alert me on EV/EBITDA

GRAIL, Inc. has no meaningful EV/EBITDA: its trailing twelve-month EBITDA is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.8× (September 2024) — the current reading is the lowest in ten years.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 0.0× —
FY2024 0.3× —
FY2023 0.0× —
FY2022 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
9 more quarters

Against its own ten years

Low 0.0× High 0.8×
Ten-year median 0.0×
Current reading's percentile 77

EV/EBITDA against peers

Company EV/EBITDA
GRAL GRAIL, Inc. n/m
ADPT Adaptive Biotechnologies Corporation compare n/m
VCYT Veracyte, Inc. compare 11.8×
SHC Sotera Health Company compare 11.9×
QGEN QIAGEN N.V. compare 17.4×
ICLR ICON PLC compare 17.9×
RDNT RadNet, Inc. compare 21.8×
CDNA CareDx, Inc. compare 26.6×
BLLN BillionToOne, Inc. compare 86.7×
Diagnostics & Research industry median 23.4×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on GRAL